The NPY-family of peptides encompasses several groups of
neurotransmitters and hormones, which exert diverse biological and
pathological actions that bear on all major vital systems. The
recognition of the role of NPY in stimulation of food intake has already
resulted in discovery of potent and selective NPY receptor Y-5
antagonists which are in clinical development for obesity while NPY Y1
receptors are targeted for cardiovascular indications. Research into the
multiple functions of NPY and its receptors in neurological and
affective disorders are also actively pursued.
This book is a unique compilation of the most recent breakthroughs in
NPY/PYY neurobiology, cardiovascular and metabolic disorders, written by
internationally renowned experts with the objective to synthesize
leading concepts and data in support for translational medicine.